Oxford spinout Ultromics lands $55M to combat hidden heart disease through earlier, smarter diagnosis
HQ: UK
Founded: 2017
Series C
Sector: Artificial Intelligence (AI)
Investment Raised: USD 55m €
Valuation Remains Undisclosed
Investors: Allegis Capital, GV, Legal & General Investment Management (LGIM), Lightrock, Oxford Science Enterprises, The Blue Venture Fund, UCM Ventures, University of Oxford, UPMC Enterprises